|
|
A TRANSLATIONAL PROGRAM OF BDNF GENE DELIVERY IN ALZHEIMER'S DISEASE |
| 5U01AG043416-03 |
TUSZYNSKI, MARK H. |
NIA |
2016 |
|
|
LEAD OPTIMIZATION OF RECEPTOR ANTAGONIST CT0093 FOR DISEASE-MODIFYING ALZHEIMER'S |
| 5U01AG047059-03 |
CATALANO, SUSAN M |
NIA |
2016 |
|
|
THE ENRGISE STUDY |
| 5U01AG050499-02 |
PAHOR, MARCO |
NIA |
2016 |
|
|
PRECLINICAL DEVELOPMENT OF A SELECTIVE SUPPRESSOR OF NEUROINFLAMMATION FOR MCI/AD |
| 5U01AG050636-02 |
VAN ELDIK, LINDA J |
NIA |
2016 |
|
|
NEURODEGENERATION IN AGING DOWN SYNDROME (NIAD): A LONGITUDINAL STUDY OF COGNITION AND BIOMARKERS OF ALZHEIMER'S DISEASE |
| 5U01AG051406-02 |
HANDEN, BENJAMIN L |
NIA |
2016 |
|
|
BIOMARKERS OF ALZHEIMER'S DISEASE IN ADULTS WITH DOWN SYNDROME |
| 5U01AG051412-02 |
SCHUPF, NICOLE |
NIA |
2016 |
|
|
MUSCLE MASS AND STRENGTH CUTPOINTS IN PERSONS AT RISK OF MOBILITY DISABILITY |
| 5U01AG051421-02 |
BHASIN, SHALENDER |
NIA |
2016 |
|
|
2016-2018 DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCES |
| 5U13AG052268-02 |
FILLIT, HOWARD M. |
NIA |
2016 |
|
|
RISK FACTORS AND PREVENTION TARGETS FOR ABNORMAL COGNITIVE AGING |
| 6K24AG046373-04 |
JEFFERSON, ANGELA L. |
NIA |
2016 |
|
|
CARDIAC FUNCTION AS A MECHANISM FOR MALADAPTIVE BRAIN AGING |
| 6R01AG034962-07 |
JEFFERSON, ANGELA L. |
NIA |
2016 |
